Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 6 Postoperative Nausea and Vomiting 3 Neoplasms 3 Prostatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Nausea 1 Myofibroma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Agnosia 1 Adenomyosis 1

Interventions

Dexamethasone 38 Aprepitant 31 Ondansetron 27 Palonosetron 25 Granisetron 16 Calcium Dobesilate 15 Olanzapine 12 Therapeutics 8 dexamethasone acetate 7 Cyclophosphamide 7 fosaprepitant 6 casopitant 6 Doxorubicin 6 Radiotherapy 5 netupitant 4 dolasetron 4 dexamethasone 21-phosphate 4 Vincristine 4 Tropisetron 4 Metoclopramide 4 Acupressure 4 Yoga 3 Psychiatric Rehabilitation 3 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Cisplatin 3 Analgesia 3 peppermint oil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nausea × ramosetron × Clear all

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡